Taiwan's biomedical park attracts interest
This article was originally published in Clinica
Construction of Taiwan's Hsinchu Biomedical Science Park is due to commence imminently. According to the department of investment services, basic facilities will be ready by June 2007, with completion scheduled for 2008-09. Planned as a major centre of R&D, industry and academia link-ups and with a functional high-tech medical centre, the park is part of Taiwan's economic reconstruction plan. The government has pledged NT$20bn (US$607m) to the project over the next five years, which it hopes will attract the interest of public and private organisations.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.